Subscribe To
Rosen, leading trial attorneys, encourages adapthealth corp. investors with losses in excess of $100k to secure counsel before important deadline in securities class action – ahco
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, an...
November 3, 2023, 8:54 pm
Open society foundations announce 2023 soros justice fellows
New York, Nov. 03, 2023 (GLOBE NEWSWIRE) — The Open Society Foundations is pleased to announce the 20...
November 3, 2023, 8:52 pm
Clearstar announces appointment of mike pritts as chief executive officer
New CEO brings a wealth of expertise to ClearStar with over 35 years of senior leadership experience in the software and technology sectors. Alpharett...
November 3, 2023, 8:50 pm
Global market weekly recap: oct. 30 – nov. 3, 2023
Equities and crypto were big winners this week as traders navigated between fresh business sentiment surveys, geopolitics and central bank statements....
November 3, 2023, 8:34 pm
Collective audience begins trading under new nasdaq ticker symbol, caud
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Collective Audience, Inc. (Nasdaq:CAUD), a leading provide...
November 3, 2023, 8:30 pm
Univest securities, llc announces closing of $10 million registered direct offering for its client gd culture group limited (nasdaq: gdc)
New York, Nov. 03, 2023 (GLOBE NEWSWIRE) — Univest Securities, LLC (“Univest”), a member of FINRA...
November 3, 2023, 8:30 pm
Cornerstone funds announce continuing monthly distributions and reset distribution amounts for 2024
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Cornerstone Strategic Value Fund, Inc. (NYSE American: CLM...
November 3, 2023, 8:30 pm
Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance
In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer vac...
November 3, 2023, 8:30 pm
Aligos therapeutics to host kol event to discuss alg-000184 phase 1, aasld late breaker data
November 16 Event to feature KOL perspective on Emerging HBV Therapies SOUTH SAN FRANCISCO, Calif., Nov. 03, 20...
November 3, 2023, 8:30 pm
Constellation brands announces expiration of canopy growth warrants
VICTOR, N.Y., Nov. 03, 2023 (GLOBE NEWSWIRE) — Constellation Brands, Inc. (NYSE: STZ), a leading beve...
November 3, 2023, 8:30 pm
Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance
In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-002 2P, an investigational therapeutic cancer vac...
November 3, 2023, 8:30 pm
Alliant energy corporation (lnt) q3 2023 earnings call transcript
Alliant Energy Corporation (NASDAQ:LNT ) Q3 2023 Earnings Conference Call November 3, 20...
November 3, 2023, 8:15 pm
The real good food company to report third quarter 2023 financial results on friday, november 10 at 10:00 a.m. eastern time
CHERRY HILL, N.J., Nov. 03, 2023 (GLOBE NEWSWIRE) — The Real Good Food Company Inc. (Nasdaq: RGF) (�...
November 3, 2023, 8:05 pm
Sensei biotherapeutics reports favorable clinical data for sns-101 at 2023 sitc annual meeting
– Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potentially best-in-class pharmacokinetics, and encourag...
November 3, 2023, 8:05 pm
Wave life sciences third quarter 2023 financial results scheduled for november 9, 2023
CAMBRIDGE, Mass., Nov. 03, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-...
November 3, 2023, 8:05 pm
Gd culture group limited announces closing of $10 million registered direct offering priced at-the-market under nasdaq rules
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — GD Culture Group Limited (“GDC” or the “Company”) ...
November 3, 2023, 8:05 pm
November 2023 letter to shareholders
VANCOUVER, Washington, Nov. 03, 2023 (GLOBE NEWSWIRE) — Dear Shareholders, We write to provide an upd...
November 3, 2023, 8:02 pm
Prime medicine reports third quarter 2023 financial results and provides business updates
— Presented new preclinical research across multiple programs, including proof-of-concept data from in vivo rodent and large animal studies, as well...
November 3, 2023, 8:01 pm
Astec to present at baird’s 2023 global industrial conference
CHATTANOOGA, Tenn., Nov. 03, 2023 (GLOBE NEWSWIRE) — Astec Industries, Inc. (NASDAQ: ASTE) announced ...
November 3, 2023, 8:01 pm
Kineta reports third quarter 2023 financial results and provides corporate update
Announced positive KVA12123 monotherapy safety data from its ongoing phase 1/2 VISTA-101 clinical trial...
November 3, 2023, 8:01 pm